Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas MacDonald

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
The interaction between chronic hepatitis B (CHB) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in a diverse central London populationEmily Martyn, Claire Mullender, Stephen Ogunnaike, et al.
Plos One|December 23, 2017
Quantification of huntingtin protein species in Huntington's disease patient leukocytes using optimised electrochemiluminescence immunoassaysDavina J Hensman Moss, Nicola Robertson, Ruth Farmer, et al.
Scientific Reports|April 25, 2017
Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood CellsJames R C Miller, Edith L Pfister, Wanzhao Liu, et al.
The Journal of Clinical Investigation|April 7, 2015
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patientsEdward J Wild, Roberto Boggio, Douglas Langbehn, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Synthesis and SAR of novel 4,5-diarylimidazolines as potent P2X7 receptor antagonistsGregory H Merriman, Liang Ma, Patrick Shum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Oxaliplatin toxicity masquerading as recurrent colon cancerGlenn Tisman, Douglas MacDonald, Neil Shindell, et al.
Molecular Cancer Therapeutics|January 22, 2017
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCsJulian Andreev, Nithya Thambi, Andres E Perez Bay, et al.
Journal of Huntington'S Disease|July 27, 2014
Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease BrainWanzhao Liu, Joanna Chaurette, Edith L Pfister, et al.
Cancer Research|February 28, 2016
Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 BlockadeAlexandra Eichten, Jia Su, Alexander P Adler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2023
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UKVictoria Hamill, Will Gelson, Douglas MacDonald, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
The interaction between chronic hepatitis B (CHB) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in a diverse central London populationEmily Martyn, Claire Mullender, Stephen Ogunnaike, et al.
Plos One|December 23, 2017
Quantification of huntingtin protein species in Huntington's disease patient leukocytes using optimised electrochemiluminescence immunoassaysDavina J Hensman Moss, Nicola Robertson, Ruth Farmer, et al.
Scientific Reports|April 25, 2017
Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood CellsJames R C Miller, Edith L Pfister, Wanzhao Liu, et al.
The Journal of Clinical Investigation|April 7, 2015
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patientsEdward J Wild, Roberto Boggio, Douglas Langbehn, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Synthesis and SAR of novel 4,5-diarylimidazolines as potent P2X7 receptor antagonistsGregory H Merriman, Liang Ma, Patrick Shum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Oxaliplatin toxicity masquerading as recurrent colon cancerGlenn Tisman, Douglas MacDonald, Neil Shindell, et al.
Molecular Cancer Therapeutics|January 22, 2017
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCsJulian Andreev, Nithya Thambi, Andres E Perez Bay, et al.
Journal of Huntington'S Disease|July 27, 2014
Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease BrainWanzhao Liu, Joanna Chaurette, Edith L Pfister, et al.
Cancer Research|February 28, 2016
Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 BlockadeAlexandra Eichten, Jia Su, Alexander P Adler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2023
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UKVictoria Hamill, Will Gelson, Douglas MacDonald, et al.
Pageof 9